Australia markets closed

ZY Jan 2023 45.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.10000.0000 (0.00%)
As of 01:32PM EDT. Market open.
Full screen
Previous close0.1000
Open0.1000
Bid0.0000
Ask0.7500
Strike45.00
Expiry date2023-01-20
Day's range0.1000 - 0.1000
Contract rangeN/A
Volume1
Open interest11
  • Motley Fool

    Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future

    Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.

  • PR Newswire

    Ginkgo to Acquire Zymergen

    Today, Ginkgo Bioworks (NYSE: DNA) — the leading horizontal platform for cell programming — and the biotechnology company Zymergen (Nasdaq: ZY) announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen stockholders will receive a